Health
New Brain Tumor Vaccine Shows Promise in Long-Term Study
A clinical study published in Nature reveals that a new therapeutic vaccine targeting aggressive brain tumors achieved a 66% survival rate after eight years.
Latest News
Volker Türk Re-elected as UN Human Rights Commissioner Amid Scrutiny
Japan Earthquake Death Toll Rises to 13 as Rescuers Search
Spain Lifts Wildfire Evacuation Orders in Three Regions
CBS Adds Ross Douthat and Norah O’Donnell to 60 Minutes
Georgia Teen Sentenced to Life Without Parole for School Shooting
Austria’s 16th-Century Bell Foundry Integrates Modern Technology
Parisian Venue Named World’s Best New Cocktail Bar
San Lorenzo: A Rebel Roman Quarter Beyond the Tourist Trail
